Illustrative image – not actual.German multinational pharmaceutical and life sciences company, Merck KGaA is likely to set up a bio-production plant in India to help local drug companies create biotech drugs and bio-similars.
The investment in the plants will be around USD 40 million. The unit will provide critical infrastructure to small biotech and biosimilar firms in the country which wish to create a process for a new biosimilar.
The investment in the plants will be around USD 40 million. The unit will provide critical infrastructure to small biotech and biosimilar firms in the country which wish to create a process for a new biosimilar.
